Head and Neck Cancer

Showing NaN - NaN of 90

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,

Not yet recruiting
  • Head and Neck Cancer
  • +2 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023

Head Neck Cancer, Dysphagia, Oropharyngeal Dysphagia Trial in Chicago, Evanston (Respiratory-Swallow Phase Training, Swallow

Recruiting
  • Head and Neck Cancer
  • +3 more
  • Respiratory-Swallow Phase Training
  • Swallow Practice
  • Chicago, Illinois
  • +1 more
Dec 13, 2022

Head Neck Cancer Trial (Retifanlimab, INCAGN02385, INCAGN02390)

Recruiting
  • Head and Neck Cancer
  • Scottsdale, Arizona
  • +87 more
Dec 12, 2022

Gastrointestinal Cancer, Breast Cancer, Head Neck Cancer Trial in Chicago (Pharmacogenomics (PGx) Testing and Genomics

Recruiting
  • Gastrointestinal Cancer
  • +4 more
  • Availability of clinical decision support based on pharmacogenomic results.
  • Chicago, Illinois
    University of Chicago Medical Center
Oct 20, 2022

Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)

Recruiting
  • Human Papilloma Virus
  • +3 more
  • Chicago, Illinois
    University of Chicago
Aug 11, 2022

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Radiation-Induced Xerostomia, Head Neck Cancer, Radiation Toxicity Trial in United States (Standard Oral Hygiene, Standard Oral

Completed
  • Radiation-Induced Xerostomia
  • +3 more
  • Standard Oral Hygiene
  • +2 more
  • Burbank, California
  • +35 more
Jul 29, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +5 more
  • IK-175 + nivolumab
  • Chicago, Illinois
  • +3 more
Jul 26, 2022

Head Neck Cancer, Dysphagia Trial in Chicago, Hines (Respiratory Swallow Training)

Recruiting
  • Head and Neck Cancer
  • Dysphagia
  • Respiratory Swallow Training
  • Chicago, Illinois
  • +1 more
Jun 10, 2022

Head Neck Cancer Trial in United States (drug, radiation, procedure)

Completed
  • Head and Neck Cancer
  • Birmingham, Alabama
  • +194 more
May 23, 2022

Solid Tumor, Adult, Squamous Cell Carcinoma of Head and Neck, Colorectal Adenocarcinoma Trial in United States (NT219, NT219 and

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Encinitas, California
  • +6 more
May 2, 2022

Head Neck Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Placebo)

Completed
  • Head and Neck Cancer
  • Nivolumab
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 24, 2022

Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in Atlanta, Chicago, Philadelphia (Pembrolizumab, Placebo)

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Atlanta, Georgia
  • +3 more
Apr 13, 2022

Head Neck Cancer Trial in Canada, Saudi Arabia, United States (cisplatin, 3-dimensional conformal radiation therapy,

Active, not recruiting
  • Head and Neck Cancer
  • Birmingham, Alabama
  • +267 more
Apr 6, 2022

Head Neck Cancer, Carcinoma, Squamous Cell, Tumors, Oral Trial in Chicago, Dallas (Intensity Modulated Radiation Therapy, chemo)

Completed
  • Head and Neck Cancer
  • +3 more
  • Chicago, Illinois
  • +1 more
Feb 16, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

Completed
  • Prostate Cancer
  • +6 more
  • MGA271
  • Los Angeles, California
  • +11 more
Feb 4, 2022

Solid Tumors, Head Neck Cancer, Lung Cancer Trial in United States (MEDI4736, INCB024360)

Completed
  • Solid Tumors
  • +3 more
  • San Francisco, California
  • +12 more
Jan 7, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab)

Recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Irvine, California
  • +10 more
Nov 4, 2021

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab, Cisplatin/Carboplatin;

Recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Irvine, California
  • +10 more
Nov 4, 2021

Head Neck Cancer Trial in United States (fruit and vegetable extracts, )

Completed
  • Head and Neck Cancer
  • fruit and vegetable extracts
  • placebo
  • Santa Rosa, California
  • +27 more
Sep 7, 2021

Head Neck Cancer Trial in Worldwide (cetuximab, intensity-modulated radiation therapy)

Active, not recruiting
  • Head and Neck Cancer
  • cetuximab
  • intensity-modulated radiation therapy
  • Birmingham, Alabama
  • +263 more
Aug 2, 2021

Head Neck Cancer Trial in Chicago (Educational website)

Terminated
  • Head and Neck Cancer
  • Educational website
  • Chicago, Illinois
    University of Illinois at Chicago
Apr 6, 2021

Head Neck Cancer Trial in Chicago (Isocaloric and iso-nitrogenous standard enteral tube feeds, Nestle IMPACT AR)

Withdrawn
  • Head and Neck Cancer
  • Isocaloric and iso-nitrogenous standard enteral tube feeds
  • Nestle IMPACT AR
  • Chicago, Illinois
    University of Illinois at Chicago
Apr 6, 2021